HDAC2 and esophageal squamous cell carcinoma: Wang’s group also suggested PAR4 activation (PAR4-AP) could inhibit the viability and induce the apoptosis of ESCC cells through suppressing enrichments of DNMT1 and HDAC2 at the p16 promoter via MAPK signals [42].